Archives: Search / 2014 / 2013 / 2012

201120102009200820072006200520042003200220012000

Category: 

Jul 21, 2014
New Data Supporting the Clinical Validity of Sequenom Laboratories' Noninvasive Prenatal Tests Presented at the 18th International Conference on Prenatal Diagnosis and Therapy
May 1, 2014
20% Year-Over-Year Increase in Total Revenues Led By Continued Growth in Diagnostic Services
Mar 5, 2014
Harry Hixson to Retire as Sequenom CEO
Feb 27, 2014
Record Quarterly and Annual Revenues; Annual Growth of 81% Over Prior Year
Jan 16, 2014
Nicox further expands North American diagnostic portfolio with access to the RetnaGene AMD test, a genetic laboratory-developed test to predict the risk of progressing to late-stage or “wet” age-related macular degeneration (AMD)
 

RSS
Contact Us

Sequenom, Inc.
Donna Nichols
Investor Relations
858-202-9028
investorrelations@
sequenom.com

Subscribe to News Alerts